Neousys Technology Inc. logo

Neousys Technology Inc. (6922)

Market Open
11 Dec, 05:30
TWSE TWSE
NT$
175. 50
+1
+0.57%
NT$
- Market Cap
- P/E Ratio
0% Div Yield
12,452 Volume
- Eps
NT$ 174.5
Previous Close
Day Range
175 177
Year Range
126.21 255.27
Want to track 6922 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6922 trading today higher at NT$175.5, an increase of 0.57% from yesterday's close, completing a monthly decrease of -5.65% or NT$10.5. Over the past 12 months, 6922 stock lost -9.75%.
6922 pays dividends to its shareholders, with the most recent payment made on Sep 19, 2025. The next estimated payment will be in In 9 months on Sep 19, 2026 for a total of NT$4.78679.
Neousys Technology Inc. has completed 1 stock splits, with the recent split occurring on Aug 21, 2025.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

6922 Chart

Neousys Technology Inc. (6922) FAQ

What is the stock price today?

The current price is NT$175.50.

On which exchange is it traded?

Neousys Technology Inc. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 6922.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

Has Neousys Technology Inc. ever had a stock split?

Neousys Technology Inc. had 1 splits and the recent split was on Aug 21, 2025.

Neousys Technology Inc. Profile

Health Care Technology Industry
Healthcare Sector
- CEO
TWSE Exchange
- ISIN
China Country
370 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cryofocus Medtech (Shanghai) Co., Ltd. is a pioneering medical device company focused on the development, manufacturing, and distribution of minimally invasive interventional cryotherapy products. The company plays a critical role in addressing a variety of cardiovascular and other significant health conditions through its innovative solutions. Established in 2013, Cryofocus Medtech is dedicated to improving patient outcomes and elevating the standard of care in the People's Republic of China. It specializes in creating cutting-edge technology for vascular interventional therapy aimed at treating atrial fibrillation, hypertension, and other cardiovascular diseases, as well as natural orifice transluminal endoscopic surgery for urinary, respiratory, and digestive diseases.

Products and Services

Bladder Cryoablation System: A state-of-the-art cryotherapy device engineered for the treatment of non-muscle-invasive bladder cancer. This innovative system offers a minimally invasive solution, aiming to reduce patient discomfort and recovery time compared to traditional treatment methods. The Bladder Cryoablation System represents a significant advancement in cancer care, providing a targeted approach to tumor treatment while minimizing damage to surrounding healthy tissue.

Endoscopic Clip for Anastomosis: An anastomotic device designed for the precise and secure closure of soft tissue within the digestive tract. This product is vital for procedures requiring the joining of tissue or organs, ensuring a seamless healing process post-surgery. The Endoscopic Clip for Anastomosis plays a crucial role in gastrointestinal surgeries, offering an innovative solution that promotes faster recovery and reduces the risk of complications associated with traditional suturing techniques.

Contact Information

Address: Building 15
Phone: 86 21 2097 7850